PMC:7534795 / 39680-40092 JSONTXT 8 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T286 0-16 Sentence denotes • TACTIC-E Trial
T287 17-71 Sentence denotes • Immunomodulatory agents • Multi-arm randomized trial
T288 72-121 Sentence denotes • Pre-intensive care unit (ICU) COVID-19 patients
T289 122-203 Sentence denotes • Immunomodulatory drug EDP1815 vs. dapagliflozin + ambrisentan vs. standard care
T290 204-340 Sentence denotes • Primary outcome includes need for cardiovascular organ support • EDP1815 as 2 capsules twice daily (1.6 × 1011 cells) for up to 7 days
T291 341-412 Sentence denotes • Dapagliflozin 10 mg + ambrisentan 5 mg once daily (NCT04393246, 2020)